Haleon (HLN) “Could be a Mini Kenvue,” Says Jim Cramer

We recently published Jim Cramer Discussed These 25 Stocks In An Important Show About AI Spending. Haleon plc (NYSE:HLN) is one of the stocks Jim Cramer recently discussed.

Haleon plc (NYSE:HLN) is a consumer products company that sells items such as toothpaste and pain relief products. The firm owns several well-known brands such as Sensodyne and Panadol. Cramer recently discussed the firm and pointed out that while it appeared to be struggling in North America, it was experiencing strong growth in regions such as Latin America and India. Haleon plc (NYSE:HLN) reported its third-quarter earnings in late October and posted a 0.4% growth in its US same-store sales that was starkly different from the 1.4% dip that analysts had forecast. Haleon plc (NYSE:HLN)’s US sales results pointed towards a tight consumer economy, as while revenue from its defensive product line, Sensodyne, grew, sales of discretionary brands dropped. Cramer remarked that Haleon plc (NYSE:HLN) could be another Kenvue without the controversies surrounding Tylenol:

Haleon (HLN) "Could be a Mini Kenvue," Says Jim Cramer

15 States with the Best Healthcare in the US

“I’ve got Haleon, which to me is kind of mini, you know Kenvue, could be a mini Kenvue, without the kind of the sticking points of Kenvue, you know like Tylenol. And then, [inaudible] going to introduce a new product into it.”

While we acknowledge the risk and potential of HLN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HLN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.